GBS most commonly stands for one of two medical conditions: Guillain-Barré Syndrome, a rare neurological disorder, or Group B Streptococcus, a type of bacteria that’s routinely screened for during pregnancy. Which meaning applies depends entirely on the context. If you encountered GBS in a neurology or autoimmune context, it refers to Guillain-Barré Syndrome. If it came up during prenatal care, it almost certainly means Group B Strep.
Guillain-Barré Syndrome
Guillain-Barré Syndrome is a condition where the immune system attacks the nerves outside the brain and spinal cord. It causes rapidly worsening weakness that typically starts in the legs and moves upward, often accompanied by tingling, numbness, and loss of reflexes. Symptoms progress over days to weeks, reaching their worst point within about four weeks.
The condition is rare, affecting roughly 1.1 people per 100,000 each year worldwide. It usually strikes after an infection. About two out of three people who develop it had diarrhea or a respiratory illness in the weeks before. The most common bacterial trigger in the United States is Campylobacter, a foodborne pathogen. Roughly 1 in every 1,000 people who get a Campylobacter infection goes on to develop Guillain-Barré Syndrome. Other known triggers include the flu, cytomegalovirus, Epstein-Barr virus, and Zika virus.
How It Damages Nerves
The problem is a case of mistaken identity. Certain infections produce molecules that closely resemble components on the surface of nerve cells. When the immune system builds antibodies to fight the infection, those antibodies also recognize and attack the protective coating around nerves (called the myelin sheath) or the nerve fibers themselves. Immune cells flood across the blood-nerve barrier, strip away myelin, and cause inflammation that disrupts the electrical signals traveling between the brain and muscles. This is why weakness spreads progressively: as more nerves lose their insulation, more muscles stop receiving clear signals.
Diagnosis
There’s no single test that confirms Guillain-Barré Syndrome. Doctors rely on a combination of clinical signs and lab work. The hallmark features are weakness in both legs (and often the arms), reduced or absent reflexes, and a pattern that worsens over days rather than months. A spinal tap often shows elevated protein levels with a normal cell count, though this classic finding only appears in about 64% of patients and depends heavily on timing. If the tap is done on the first day of weakness, only about half of patients show the protein spike; after two weeks, that number rises to 88%. Nerve conduction studies, which measure how quickly electrical signals travel through nerves, show abnormalities in roughly 99% of cases.
Recovery and Outlook
Most people recover, but the timeline is long. In a large study of 297 patients, only 24% had recovered by four weeks. By six months, 57% had recovered. By two years, the number reached 82%. About 16% were left with lasting neurological problems such as weakness or difficulty walking, and 11% died, typically from complications like respiratory failure. Younger patients and those with milder initial symptoms tend to have better outcomes. Recovery happens because the body can rebuild damaged myelin, though the process of re-insulating nerves takes months.
Group B Streptococcus
Group B Strep is a completely different use of the same abbreviation. It refers to Streptococcus agalactiae, a bacterium that naturally lives in the gastrointestinal and genital tracts of up to 35% of healthy women. Carrying it doesn’t mean you’re sick. Most people who have it never develop any symptoms and may never know it’s there.
The concern with Group B Strep is primarily about pregnancy and childbirth. A mother who carries the bacteria can pass it to her baby during delivery. In newborns, whose immune systems are still immature, GBS can cause serious infections including sepsis (a dangerous whole-body inflammatory response), pneumonia, and meningitis (infection of the membranes surrounding the brain and spinal cord). Most babies who develop GBS disease in their first week of life were exposed during birth.
Screening During Pregnancy
Because the bacteria are so common and the risks to newborns are serious, screening is standard practice. The American College of Obstetricians and Gynecologists recommends that all pregnant women be tested for Group B Strep between 36 and 37 weeks of pregnancy. The test is a simple swab of the vaginal and rectal areas. If you test positive, you’ll receive antibiotics through an IV during labor to reduce the chance of passing the bacteria to your baby. This approach has dramatically lowered the rate of newborn GBS infections since it became routine.
Testing positive for GBS doesn’t mean anything is wrong with you or that your pregnancy is high-risk. It simply means the bacteria are present and that a straightforward preventive step is needed during delivery.
How to Tell Which GBS Is Being Discussed
The context usually makes it obvious. If GBS appears in a conversation about pregnancy, prenatal testing, or newborn health, it means Group B Strep. If it comes up alongside terms like autoimmune, nerve damage, paralysis, or weakness, it means Guillain-Barré Syndrome. The two conditions are entirely unrelated: one is a bacterial colonization, the other is an immune system disorder. They share nothing except an abbreviation.